In the GPA subgroup, pr3-ANCA positivity reached 90.9%, with ENT involvement in 81.8%, consistent with the classical GPA phenotype and prior reports linking pr3-ANCA with upper respiratory tract manifestations and distinct relapse patterns [28,29,30]. This evidence concerns the gene PRTN3 and granulomatosis with polyangiitis.